EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

A scoping review of MRI skin changes and pathologic dermal involvement in breast cancer

Meghan H. Maceyko, Jasmine Phun, Kristina McShea, Elizabeth M. De Jesus, Margaret S. Pichardo, Christine E. Edmonds, Oluwadamilola M. Fayanju

Surgical Oncology Insight · 2026-12 · 3 (4) · 100304

DOI: 10.1016/j.soi.2026.100304 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Surgical Oncology Insight, 2026-12. Verfasst von Meghan H. Maceyko und 6 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Breast Cancer Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast MRI frequently demonstrates skin thickening and enhancement, yet their association with pathologic dermal involvement remains unclear. Accurate assessment of dermal disease is critical for surgical planning, particularly in inflammatory breast cancer (IBC), where MRI is often used to evaluate response to neoadjuvant systemic therapy (NST).

Methods

We conducted a scoping review in accordance with PRISMA-ScR guidelines. PubMed/MEDLINE, Embase, Cochrane Library, and Scopus were searched for studies evaluating MRI-detected skin changes and histopathologic dermal involvement in adults with invasive breast cancer. Studies were screened using predefined criteria, and data were synthesized descriptively.

Results

A total of 1,085 records were identified, with six studies (n=149 patients) meeting inclusion criteria. In the pretreatment setting, MRI-detected skin thickening and enhancement were variably present and not consistently associated with dermal invasion, although skin thickening was more common in IBC. Post-treatment, both skin thickening and enhancement frequently persisted after NST but did not reliably correlate with residual dermal disease or pathologic response.

Conclusions

MRI-detected skin changes, including thickening and enhancement, are not reliable indicators of pathologic dermal involvement in breast cancer. These findings should be interpreted within the broader clinical context, particularly in IBC. Further prospective studies with standardized imaging criteria and pathologic correlation are needed to improve diagnostic accuracy and inform surgical decision-making.

Förderung

  • Breast Cancer Research Foundation

Zitieren

APA

Maceyko, M. H., Phun, J., McShea, K., Jesus, E. M. D., Pichardo, M. S., Edmonds, C. E., & Fayanju, O. M. (2026). A scoping review of MRI skin changes and pathologic dermal involvement in breast cancer. Surgical Oncology Insight, 3(4), 100304. https://doi.org/10.1016/j.soi.2026.100304

Vancouver

Maceyko MH, Phun J, McShea K, Jesus EMD, Pichardo MS, Edmonds CE, et al. A scoping review of MRI skin changes and pathologic dermal involvement in breast cancer. Surgical Oncology Insight. 2026;3(4):100304. doi:10.1016/j.soi.2026.100304

BibTeX
@article{Maceyko2026,
  author = {Maceyko, Meghan H. and Phun, Jasmine and McShea, Kristina and Jesus, Elizabeth M. De and Pichardo, Margaret S. and Edmonds, Christine E. and Fayanju, Oluwadamilola M.},
  title = {A scoping review of MRI skin changes and pathologic dermal involvement in breast cancer},
  journal = {Surgical Oncology Insight},
  year = {2026},
  volume = {3},
  number = {4},
  pages = {100304},
  doi = {10.1016/j.soi.2026.100304}
}
Kostenlos starten →